Can giving Tylenol to babies increase the risk of asthma or other allergies?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Was this fact-check helpful?
1. Summary of the results
The relationship between giving Tylenol to babies and the risk of asthma or other allergies is inconclusive, with various studies presenting conflicting evidence [1]. Some analyses suggest an association between acetaminophen use in children and the development of asthma [2], with a 28% increased risk of developing asthma symptoms by age three for every doubling of the number of days an infant was given acetaminophen [2]. However, other studies have found no association between acetaminophen use and asthma [1], and controlling for respiratory infections in infancy may diminish the associations observed for infant antipyretic intake and asthma-related outcomes [3]. Experimental studies on rats have shown a possible biological link to allergic rhinitis [4], and a systematic meta-analysis of 18 observational studies found that acetaminophen exposure is associated with a higher odds of allergic rhinitis [5]. On the other hand, some studies have found no data on asthma, allergic reactions, or long-term immunologic outcomes [6], and reviews of acetaminophen pharmacology and dosing have not discussed asthma or allergic disease [7].
2. Missing context/alternative viewpoints
A key missing context in the original statement is the importance of controlling for confounding variables, such as respiratory infections in infancy, which may play a role in the relationship between acetaminophen use and asthma [3]. Additionally, the biological mechanisms underlying the potential link between acetaminophen use and asthma or allergies are not fully understood [8]. Alternative viewpoints include the possibility that early-life exposure to acetaminophen may be more strongly associated with an increased risk of allergic rhinitis [5], and that higher frequency use of acetaminophen may also increase this risk [5]. Furthermore, the lack of well-designed birth-cohort studies and the presence of recall bias in some studies may limit the conclusions that can be drawn from the available evidence [8].
3. Potential misinformation/bias in the original statement
The original statement may be misleading in suggesting a causal link between giving Tylenol to babies and an increased risk of asthma or allergies, as the evidence remains inconclusive [1]. The statement may benefit pharmaceutical companies that produce alternative pain relievers, or organizations that promote natural health practices, by creating concern about the safety of acetaminophen use in infants [2]. On the other hand, the statement may also benefit parents and caregivers who are concerned about the health and well-being of their children, by highlighting the potential risks associated with acetaminophen use [1]. However, it is essential to consider the potential biases and limitations of the available evidence, including the funding sources and affiliations of the researchers, to ensure that the information is accurate and unbiased [8].